[HTML][HTML] cAMP-PKA cascade: An outdated topic for depression?

F Gao, S Yang, J Wang, G Zhu - Biomedicine & Pharmacotherapy, 2022 - Elsevier
Depression is a common neuropsychiatric disorder characterized by persistent depressed
mood and causes serious socioeconomic burden worldwide. Hyperactivity of the …

Phosphodiesterase inhibitors say NO to Alzheimer's disease

SM Nabavi, S Talarek, J Listos, SF Nabavi… - Food and Chemical …, 2019 - Elsevier
Phosphodiesterases (PDEs) consisted of 11 subtypes (PDE1 to PDE11) and over 40
isoforms that regulate levels of cyclic guanosine monophosphate (cGMP) and cyclic …

[HTML][HTML] Beyond PDE4 inhibition: A comprehensive review on downstream cAMP signaling in the central nervous system

Z Donders, IJ Skorupska, E Willems, F Mussen… - Biomedicine & …, 2024 - Elsevier
Cyclic adenosine monophosphate (cAMP) is a key second messenger that regulates signal
transduction pathways pivotal for numerous biological functions. Intracellular cAMP levels …

Pivotal role of choline metabolites in remyelination

T Skripuletz, A Manzel, K Gropengießer, N Schäfer… - Brain, 2015 - academic.oup.com
Neuroprotective approaches for central nervous system regeneration have not been
successful in clinical practice so far and compounds that enhance remyelination are still not …

Neuronal activity and remyelination: new insights into the molecular mechanisms and therapeutic advancements

Y Zhou, J Zhang - Frontiers in Cell and Developmental Biology, 2023 - frontiersin.org
This article reviews the role of neuronal activity in myelin regeneration and the related
neural signaling pathways. The article points out that neuronal activity can stimulate the …

Oligodendrocyte precursor cells as a therapeutic target for demyelinating diseases

SD Skaper - Progress in Brain Research, 2019 - Elsevier
The mechanisms regulating differentiation of multipotent oligodendrocyte progenitor cells
(OPCs) into mature oligodendrocytes (OLs) are critical to our understanding of myelination …

Phosphodiesterase inhibitors as a therapeutic approach to neuroprotection and repair

EP Knott, M Assi, SNR Rao, M Ghosh… - International journal of …, 2017 - mdpi.com
A wide diversity of perturbations of the central nervous system (CNS) result in structural
damage to the neuroarchitecture and cellular defects, which in turn are accompanied by …

cAMP-specific phosphodiesterase inhibitors: promising drugs for inflammatory and neurological diseases

A Martinez, C Gil - Expert opinion on therapeutic patents, 2014 - Taylor & Francis
Introduction: PDEs are key enzymes in the adenosine and guanosine cyclic nucleotides
(cAMP and cGMP) signaling cascade. Their inhibition increases cyclic nucleotide levels …

The orphan G protein-coupled receptor GPR17 negatively regulates oligodendrocyte differentiation via Gαi/o and its downstream effector molecules

K Simon, S Hennen, N Merten, S Blättermann… - Journal of Biological …, 2016 - ASBMB
Recent studies have recognized G protein-coupled receptors as important regulators of
oligodendrocyte development. GPR17, in particular, is an orphan G protein-coupled …

Advances in the development of phosphodiesterase 7 inhibitors

JX Huang, BL Zhu, JP Xu, ZZ Zhou - European Journal of Medicinal …, 2023 - Elsevier
Abstract Phosphodiesterase 7 (PDE7) specifically hydrolyzes cyclic adenosine
monophosphate (cAMP), a second messenger that plays essential roles in cell signaling …